Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150069 · ClinicalTrials.gov registry record
Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 18
- Enrollment target
NCT03150069: Completed study, sponsored by Emory University.
NCT03150069 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150069 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The present study seeks to interview women with Morquio A and Morquio B syndrome, to explore their concerns surrounding pregnancy and the impact of ERT on their perspectives, in comparison with the control group of Morquio B subjects for whom no ERT treatment exists. Interviews will be conducted by a health psychologist, in-person or over the telephone. Data will be analyzed using MAXQDA 12.0 software and Grounded Theory. Differences in thematic trends between Morquio A subjects, for whom treatment exists, and a control group of Morquio B subjects, for whom there is no treatment, will be compared.
Primary Outcome
Completion of in-depth interview
Interventions
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2018-08-17 |
What the finished NCT03150069 record still lists
NCT03150069 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT03150069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03150069 about?
NCT03150069 is a clinical study titled "Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?". The present study seeks to interview women with Morquio A and Morquio B syndrome, to explore their concerns surrounding pregnancy and the impact of ERT on their perspectives, in comparison with the control group of Morquio B subjects for whom no ERT treatment exists. Interviews will be conducted by...
What is the current status of trial NCT03150069?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2017-05-10. Estimated completion is 2018-08-17.
What interventions are being tested in trial NCT03150069?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT03150069?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI